Extracorporeal Membrane Oxygenation (ECMO): Blood Cells
Terminated
- Conditions
- Extracorporeal Membrane Oxygenation
- Registration Number
- NCT02748668
- Lead Sponsor
- Spectrum Health Hospitals
- Brief Summary
The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 371
Inclusion Criteria
- Greater than or equal to 18 years of age
- Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy.
Exclusion Criteria
- Subject is less than 18 years of age
- Known prisoner
Control Subjects:
Inclusion Criteria
- Greater than 18 years of age
- Without any known cardiovascular, lung, or autoimmune disease.
Exclusion Criteria:
- Less than or equal to 18 years of age
- Known cardiovascular, lung, or autoimmune disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All cause mortality 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Spectrum Health
🇺🇸Grand Rapids, Michigan, United States
Spectrum Health🇺🇸Grand Rapids, Michigan, United States